Link Pharma Chem Ltd
₹ 42.1
0.29%
28 Mar
- close price
About
Incorporated in 1986, Link Pharma Chem Ltd is engaged in the manufacturing and job work of organic intermediates.
Key Points
- Market Cap ₹ 18.7 Cr.
- Current Price ₹ 42.1
- High / Low ₹ 68.8 / 34.1
- Stock P/E
- Book Value ₹ 29.6
- Dividend Yield 0.00 %
- ROCE 6.72 %
- ROE 3.86 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 43.0 to 34.2 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company has a low return on equity of 8.00% over last 3 years.
- Working capital days have increased from 48.1 days to 90.6 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
17.51 | 16.36 | 23.59 | 17.58 | 12.35 | 16.10 | 23.53 | 24.50 | 25.47 | 34.81 | 53.56 | 38.76 | 31.16 | |
15.75 | 14.20 | 21.25 | 18.36 | 12.16 | 13.56 | 20.75 | 22.48 | 22.05 | 31.67 | 50.02 | 36.04 | 32.43 | |
Operating Profit | 1.76 | 2.16 | 2.34 | -0.78 | 0.19 | 2.54 | 2.78 | 2.02 | 3.42 | 3.14 | 3.54 | 2.72 | -1.27 |
OPM % | 10.05% | 13.20% | 9.92% | -4.44% | 1.54% | 15.78% | 11.81% | 8.24% | 13.43% | 9.02% | 6.61% | 7.02% | -4.08% |
0.28 | 0.15 | 0.26 | 0.21 | 2.39 | -0.43 | 0.07 | 0.19 | -0.69 | -0.15 | 0.46 | -0.15 | 0.62 | |
Interest | 0.87 | 1.21 | 1.14 | 1.44 | 0.91 | 0.80 | 0.62 | 0.39 | 0.36 | 0.44 | 0.45 | 0.76 | 0.94 |
Depreciation | 0.48 | 0.60 | 0.79 | 1.13 | 0.93 | 0.83 | 0.86 | 0.89 | 0.93 | 0.87 | 0.93 | 0.92 | 1.02 |
Profit before tax | 0.69 | 0.50 | 0.67 | -3.14 | 0.74 | 0.48 | 1.37 | 0.93 | 1.44 | 1.68 | 2.62 | 0.89 | -2.61 |
Tax % | 27.54% | 42.00% | 23.88% | 29.94% | 20.27% | 54.17% | 17.52% | 29.03% | 34.03% | 35.12% | 28.24% | 26.97% | |
0.50 | 0.29 | 0.52 | -2.20 | 0.59 | 0.23 | 1.13 | 0.66 | 0.95 | 1.08 | 1.88 | 0.65 | -1.81 | |
EPS in Rs | 1.13 | 0.65 | 1.17 | -4.95 | 1.33 | 0.52 | 2.54 | 1.49 | 2.14 | 2.43 | 4.23 | 1.46 | -4.08 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 11% |
3 Years: | 15% |
TTM: | -24% |
Compounded Profit Growth | |
---|---|
10 Years: | 7% |
5 Years: | -13% |
3 Years: | -29% |
TTM: | -262% |
Stock Price CAGR | |
---|---|
10 Years: | 18% |
5 Years: | 11% |
3 Years: | 21% |
1 Year: | 16% |
Return on Equity | |
---|---|
10 Years: | 4% |
5 Years: | 9% |
3 Years: | 8% |
Last Year: | 4% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 |
Reserves | 5.42 | 5.71 | 6.23 | 3.93 | 4.52 | 4.16 | 5.35 | 5.94 | 6.99 | 8.12 | 10.03 | 10.60 | 8.70 |
6.14 | 8.94 | 9.08 | 10.80 | 5.41 | 4.73 | 2.71 | 2.64 | 3.56 | 3.66 | 6.39 | 8.76 | 8.90 | |
7.03 | 6.04 | 6.60 | 7.35 | 3.46 | 3.81 | 4.69 | 4.99 | 3.98 | 9.82 | 8.10 | 8.66 | 5.25 | |
Total Liabilities | 23.03 | 25.13 | 26.35 | 26.52 | 17.83 | 17.14 | 17.19 | 18.01 | 18.97 | 26.04 | 28.96 | 32.46 | 27.29 |
5.19 | 13.82 | 14.59 | 17.51 | 10.13 | 9.57 | 9.76 | 9.14 | 8.81 | 8.71 | 8.79 | 9.00 | 8.76 | |
CWIP | 10.16 | 1.53 | 1.92 | 0.00 | 0.00 | 0.00 | 0.01 | 0.43 | 0.00 | 0.00 | 0.21 | 0.00 | 0.00 |
Investments | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 4.52 | 3.64 | 2.54 |
7.66 | 9.76 | 9.82 | 8.99 | 7.68 | 7.54 | 7.39 | 8.41 | 10.13 | 17.30 | 15.44 | 19.82 | 15.99 | |
Total Assets | 23.03 | 25.13 | 26.35 | 26.52 | 17.83 | 17.14 | 17.19 | 18.01 | 18.97 | 26.04 | 28.96 | 32.46 | 27.29 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3.04 | -0.84 | 0.87 | 5.13 | -3.91 | 2.23 | 3.79 | 1.36 | 2.95 | 4.84 | -1.26 | -1.71 | |
-2.05 | -0.62 | -1.14 | -3.27 | 8.72 | -0.73 | -1.15 | -0.96 | -1.66 | -2.16 | -4.97 | -0.08 | |
-1.52 | 1.35 | 0.30 | -0.87 | -5.75 | -1.48 | -2.63 | -0.46 | 0.55 | -0.33 | 2.27 | 1.61 | |
Net Cash Flow | -0.53 | -0.11 | 0.03 | 0.99 | -0.94 | 0.02 | 0.00 | -0.05 | 1.85 | 2.35 | -3.95 | -0.17 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 49.40 | 71.62 | 51.06 | 63.74 | 68.86 | 49.42 | 49.33 | 45.29 | 71.51 | 58.19 | 36.60 | 34.18 |
Inventory Days | 156.72 | 261.84 | 143.28 | 125.34 | 277.34 | 285.97 | 96.96 | 92.54 | 60.04 | 51.35 | 47.68 | 209.23 |
Days Payable | 102.28 | 98.25 | 110.60 | 94.59 | 81.61 | 202.93 | 124.25 | 108.98 | 110.86 | 140.70 | 45.37 | 112.90 |
Cash Conversion Cycle | 103.84 | 235.20 | 83.74 | 94.49 | 264.59 | 132.47 | 22.05 | 28.85 | 20.68 | -31.16 | 38.90 | 130.51 |
Working Capital Days | 13.34 | 87.90 | 52.14 | 39.45 | 91.32 | 75.49 | 34.59 | 41.27 | 51.45 | 15.73 | 37.96 | 90.59 |
ROCE % | 9.43% | 9.75% | 9.32% | -8.74% | -3.64% | 13.00% | 15.41% | 10.34% | 18.71% | 14.61% | 13.16% | 6.72% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
8m - Order received from Assistant Commissioner, Central GST & Central Excise, Vadodara for raising GST demand together with interest and penalty.
- Closure of Trading Window 1d
- Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Sale Of Unutilized Office Located At Vadodara. 15 Mar
- Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Sale Of Unutilized Office Located At Vadodara. 14 Mar
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 7 Mar
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1]
Company manufactures and exports multi range intermediates for pharmaceutical, agro industries and specialty chemicals. It is also engaged in custom synthesis/contract manufacturing for multistage synthesis for small, medium, large companies.